SANOFINSESanofi India Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 25 Jun · 13:26 IST

Sanofi India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sanofi India has informed stock exchanges that its trading window will remain closed starting 1st July 2025 until 48 hours after the announcement of its financial results for the quarter and half-year ending 30th June 2025. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015, and applies to designated persons of the company. The closure is meant to prevent insider trading ahead of the upcoming results announcement. The filing was made by the Company Secretary on 25th June 2025.

Likely market impact

This is a routine regulatory disclosure and does not directly impact the stock price. It signals that Q1 FY26 results are expected soon, which investors should watch for as it will provide the next fundamental update on the company's performance.